The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
暂无分享,去创建一个
Voichita D. Marinescu | S. Nelander | I. Alafuzoff | E. Holland | B. Westermark | A. Segerman | K. Forsberg-Nilsson | Mia Niklasson | S. Libard | G. Hesselager | Isabelle Everlien | A. Hermansson | S. Sreedharan | G. Wicher | Yuan Xie | L. Uhrbom | Yiwen Jiang | T. Bergström | Patrik Johansson | N. Lindberg | Sathishkumar Baskaran | M. Kastemar | Lioudmila Elfineh | Sven Nelander | Tobias Bergström | Sylwia Libard | Lene Uhrbom
[1] Joshua M. Korn,et al. Studying clonal dynamics in response to cancer therapy using high-complexity barcoding , 2015, Nature Medicine.
[2] B. Birnir,et al. Etomidate, propofol and diazepam potentiate GABA-evoked GABAA currents in a cell line derived from human glioblastoma. , 2015, European journal of pharmacology.
[3] Voichita D. Marinescu,et al. Selective Calcium Sensitivity in Immature Glioma Cancer Stem Cells , 2014, PloS one.
[4] Gary D Bader,et al. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity , 2015, Proceedings of the National Academy of Sciences.
[5] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[6] S. Nelander,et al. RETRACTED: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule , 2014, Cell.
[7] M. J. van den Bent,et al. Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules. , 2013, Neuro-oncology.
[8] C. Brennan,et al. Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates , 2013, Acta Neuropathologica.
[9] S. Nelander,et al. Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions. , 2013, Neuro-oncology.
[10] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[11] Se Hoon Kim,et al. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. , 2013, Cancer cell.
[12] Daniela M. Witten,et al. An Introduction to Statistical Learning: with Applications in R , 2013 .
[13] C. Heldin,et al. Snail depletes the tumorigenic potential of glioblastoma , 2013, Oncogene.
[14] Anders Isaksson,et al. Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue , 2013, Genome Biology.
[15] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[16] H. Woo,et al. Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. , 2013, Cell reports.
[17] N. Maitland,et al. Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures , 2013, PloS one.
[18] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[19] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[20] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[21] M. Weller,et al. Isocitrate dehydrogenase mutations: A challenge to traditional views on the genesis and malignant progression of gliomas , 2011, Glia.
[22] Helmut Kettenmann,et al. The brain tumor microenvironment , 2011, Glia.
[23] Amanda Capes-Davis,et al. Check your cultures! A list of cross‐contaminated or misidentified cell lines , 2010, International journal of cancer.
[24] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[25] R. McLendon,et al. Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.
[26] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[27] J. Pontén,et al. Long term culture of normal and neoplastic human glia. , 2009, Acta pathologica et microbiologica Scandinavica.
[28] J. Pontén,et al. Determinants for the establishment of permanent tissue culture lines from human gliomas. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[29] Mark Bernstein,et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. , 2009, Cell stem cell.
[30] H. Fine,et al. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. , 2009, Cell stem cell.
[31] S. Horvath,et al. Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma , 2009, Stem cells.
[32] Tatsuya Ozawa,et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.
[33] J. Fawcett,et al. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours , 2009, Journal of Neuroscience Methods.
[34] Peter Canoll,et al. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. , 2008, Neurosurgery.
[35] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[36] Alexander Brawanski,et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.
[37] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[38] M. Frotscher,et al. Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology , 2006, Nature Methods.
[39] Yuri Kotliarov,et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.
[40] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[41] Austin G Smith,et al. Niche-Independent Symmetrical Self-Renewal of a Mammalian Tissue Stem Cell , 2005, PLoS biology.
[42] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[43] Ugo Orfanelli,et al. Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.
[44] Jens Nilsson,et al. Approximate geodesic distances reveal biologically relevant structures in microarray data , 2004, Bioinform..
[45] Daniel H. Geschwind,et al. Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[46] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[47] L. Pevny,et al. SOX2 Functions to Maintain Neural Progenitor Identity , 2003, Neuron.
[48] D. Steindler,et al. Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. Steindler,et al. Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro , 2002, Glia.
[50] J. Tenenbaum,et al. A global geometric framework for nonlinear dimensionality reduction. , 2000, Science.
[51] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[52] U. Lendahl,et al. Expression of the class VI intermediate filament nestin in human central nervous system tumors. , 1992, Cancer research.
[53] R. McKay,et al. CNS stem cells express a new class of intermediate filament protein , 1990, Cell.
[54] C. Kruchko,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.
[55] Tzong-Shiue Yu,et al. A restricted cell population propagates glioblastoma growth after chemotherapy , 2012 .
[56] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[57] P. Loehrer. Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma , 2006 .
[58] R. Bjerkvig,et al. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model , 2002, Acta Neuropathologica.